|| Checking for direct PDF access through Ovid
Asbestos exposure can cause malignant mesothelioma and lung cancer. However, in contrast, its effect on anti-tumour immunity remains unclear. Our previous study reported that asbestos exposure suppressed the induction of CTL during mixed lymphocyte reactions (MLR), accompanied by the decrease in proliferation of CD8+T cells. Recently, we reported that IL-2 showed a tendency to increase% granzyme B+ cells in the CFSE-positive CD8+ lymphocytes without proliferation upon exposure to asbestos. Therefore, we investigated whether IL-15 addition might improve the suppressed induction of CTL upon exposure to asbestos.For MLR, human PBMCs were cultured with irradiated allogenic PBMCs upon exposure to chrysotile B asbestos at 5 μg/ml for 7 days. After 2 days of culture, IL-15 was added at 1 ng/ml. After 7 days of MLR, PBMCs were collected and analysed for phenotypic and functional markers of CD8+ T cells with fluorescence-labelled anti-CD3, anti-CD8, anti-CD45RA, anti-CD45RO, and anti-granzyme B Abs using flow cytometry.IL-15 didn’t recover the asbestos-caused decreases in% CD25+ and% CD45RO+ cells and increase in% CD45RA+ cells, but recovered the decrease in cell numbers of CD3+CD8+ cells and% granzyme B+ cells, in contrast to IL-2.These results indicate that IL-15 is more effective on recovery from asbestos-caused suppressed induction of CTL than IL-2, although the interfered expressions of cell surface markers were not recovered even by addition of IL-15. Further study about the characteristics of CD3+CD8+granzyme B+ cells induced by addition of IL-15 will contribute to clarification for the mechanism of asbestos-caused suppression in CTL induction and to finding out a clue to restore it.